MiMedx Shares to Commence Trading on Nasdaq on Wednesday, November 4, 2020
November 03 2020 - 5:30PM
MiMedx Group, Inc. (OTC PINK: MDXG) (“MiMedx” or the “Company”), an
industry leader in advanced wound care and a therapeutic biologics
company, today confirmed that the Company’s common stock will
commence trading on The Nasdaq Stock Market at the opening of
trading on Wednesday, November 4, 2020, under the ticker symbol
“MDXG”.
About MiMedx
MiMedx® is an industry leader in advanced wound
care and a therapeutic biologics company developing and
distributing human placental tissue allografts with
patent-protected processes for multiple sectors of healthcare. The
Company processes the human placental tissue utilizing its
proprietary PURION® process methodology, among other processes, to
produce allografts by employing aseptic processing techniques in
addition to terminal sterilization. MiMedx has supplied over two
million allografts, through both direct and consignment shipments.
For additional information, please visit www.mimedx.com.
Contact
Hilary DixonInvestor Relations & Corporate
Communications770.651.9066investorrelations@mimedx.com
MiMedx (NASDAQ:MDXG)
Historical Stock Chart
From Mar 2024 to Apr 2024
MiMedx (NASDAQ:MDXG)
Historical Stock Chart
From Apr 2023 to Apr 2024